185 related articles for article (PubMed ID: 15138605)
21. Exogenous wild-type p16INK4A gene induces delayed cell proliferation and promotes chemosensitivity through decreased pRB and increased E2F-1 expressions.
Jeong YW; Kim KS; Oh JY; Park JC; Baek WK; Suh SI; Suh MH; Lee JC; Cho JW
Int J Mol Med; 2003 Jul; 12(1):61-5. PubMed ID: 12792810
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Landberg G; Nielsen NH; Nilsson P; Emdin SO; Cajander J; Roos G
Cancer Res; 1997 Feb; 57(3):549-54. PubMed ID: 9012489
[TBL] [Abstract][Full Text] [Related]
23. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
Shapiro GI; Edwards CD; Rollins BJ
Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
[TBL] [Abstract][Full Text] [Related]
24. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation.
Kobayashi S; Shirasawa H; Sashiyama H; Kawahira H; Kaneko K; Asano T; Ochiai T
Clin Cancer Res; 1999 Dec; 5(12):4182-5. PubMed ID: 10632358
[TBL] [Abstract][Full Text] [Related]
25. Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue.
Van Zee KJ; Calvano JE; Bisogna M
Oncogene; 1998 May; 16(21):2723-7. PubMed ID: 9652738
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of telomerase limits the growth of human cancer cells.
Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
[TBL] [Abstract][Full Text] [Related]
27. Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion.
Olsen CL; Gardie B; Yaswen P; Stampfer MR
Oncogene; 2002 Sep; 21(41):6328-39. PubMed ID: 12214273
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
Campbell I; Magliocco A; Moyana T; Zheng C; Xiang J
Cancer Gene Ther; 2000 Sep; 7(9):1270-8. PubMed ID: 11023200
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.
Lebeau J; Fouchet P; Ory K; Chevillard S
Anticancer Res; 2002; 22(4):2161-6. PubMed ID: 12174898
[TBL] [Abstract][Full Text] [Related]
30. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.
Noonan DM; Severino A; Morini M; Tritarelli A; Manente L; D'Agnano I; Starace G; Baldi A; Lombardi D; Albini A; Felsani A; Paggi MG
J Cell Physiol; 2005 Mar; 202(3):922-8. PubMed ID: 15389561
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
33. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
[TBL] [Abstract][Full Text] [Related]
34. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
Milyavsky M; Shats I; Erez N; Tang X; Senderovich S; Meerson A; Tabach Y; Goldfinger N; Ginsberg D; Harris CC; Rotter V
Cancer Res; 2003 Nov; 63(21):7147-57. PubMed ID: 14612508
[TBL] [Abstract][Full Text] [Related]
35. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
[TBL] [Abstract][Full Text] [Related]
36. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
37. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells].
Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
Ai Zheng; 2004 May; 23(5):545-9. PubMed ID: 15142451
[TBL] [Abstract][Full Text] [Related]
39. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state.
Timmermann S; Hinds PW; Münger K
Oncogene; 1998 Dec; 17(26):3445-53. PubMed ID: 10030668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
